ArticlePrzeglad gastroenterologiczny2026
Guidelines for the management of coeliac disease: recommendations of the Intestinal Diseases Section of the Polish Society of Gastroenterology.
Article in Przeglad gastroenterologiczny, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
These guidelines, developed by the Intestinal Diseases Section of the Polish Society of Gastroenterology, aim to improve and standardise the quality of care for patients with coeliac disease. The recommendations are based on the latest scientific evidence and current guidelines published by other recognised international expert societies. The recommendations were created using a methodology adapted from the GRADE system. The final consensus statements were evaluated by a panel of Polish experts using a Likert scale, with a high degree of consensus (greater than 75%) established as the threshold for acceptance. The document was also reviewed in consultation with representatives of coeliac disease patient advocacy groups. For diagnostic algorithms, testing for anti-tissue transglutaminase IgA antibodies combined with the level of total serum IgA is recommended as the first-line screening tool. Gastroduodenoscopy with duodenal biopsy is advised as the subsequent diagnostic step; however, specific criteria for a non-biopsy approach in selected groups of both paediatric and adult patients were also defined. Strict adherence to a gluten-free diet remains the cornerstone of treatment. Furthermore, the guidelines establish principles for disease monitoring, provide detailed differential diagnosis for other gluten-related disorders, and outline management algorithms for non-responsive and refractory coeliac disease. The recommendations of the Polish Society of Gastroenterology provide structured, practical tools for the diagnosis, differentiation, treatment, and monitoring of coeliac disease, thereby optimising clinical decision-making and emphasising an interdisciplinary model of medical care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.